LENVATOL 10MG INJ.

Product Description

Product Description for LENVATOL 10MG Injection (B2B Market)

Brand Name: LENVATOL
Strength: 10 mg
Form: Injection
Therapeutic Category: Anticancer, Targeted Therapy
Manufacturer: [Manufacturer Name]
Pack Size: Vial (1 vial per pack)

Indication:
LENVATOL 10mg Injection is primarily used in the treatment of various cancers. It is indicated for patients with:

• Hepatocellular Carcinoma (HCC)
• Thyroid Cancer
• Renal Cell Carcinoma (RCC)
• Other solid tumors, as per healthcare provider recommendations

LENVATOL (Lenvatinib) is a tyrosine kinase inhibitor (TKI) that works by inhibiting several receptors involved in tumor growth, angiogenesis, and cancer cell survival, helping to slow down or stop the progression of cancer.

Mechanism of Action:
LENVATOL is a potent oral multikinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR1-3), fibroblast growth factor receptors (FGFR1-4), platelet-derived growth factor receptors (PDGFR-), KIT, and RET. By blocking these pathways, LENVATOL reduces angiogenesis (the formation of new blood vessels that tumors need to grow) and inhibits tumor cell proliferation, leading to the slowing or arrest of cancer progression.

Dosage and Administration:
LENVATOL 10mg Injection is administered via intravenous (IV) injection. The exact dosage regimen depends on the patient's specific condition and response to treatment, as determined by the prescribing healthcare provider. It is important to adhere to the recommended dosage schedule to ensure optimal therapeutic outcomes.

Key Features:

• High Efficacy: Proven effectiveness in treating multiple cancers, including liver, thyroid, and renal cancers.
• Targeted Action: Focuses on the inhibition of key signaling pathways in cancer progression.
• Well-Tolerated: Generally well tolerated with a manageable side-effect profile.
• Fast Acting: Demonstrates a rapid onset of action, with noticeable improvement in symptoms and disease progression.
• Reliable Quality: Manufactured by [Manufacturer Name], adhering to global standards of pharmaceutical quality and safety.

Packaging:
Each vial contains 10 mg of Lenvatinib in sterile solution. Available in packs of [insert number] vials per box.

Storage Instructions:

• Store at 2C to 8C (36F to 46F).
• Keep away from light.
• Do not freeze.

Contraindications:

• Hypersensitivity to lenvatinib or any component of the formulation.
• Not recommended during pregnancy or breastfeeding.

Side Effects:
Common side effects may include fatigue, hypertension, diarrhea, decreased appetite, and hand-foot skin reactions. Serious side effects may involve liver problems, bleeding, and gastrointestinal perforation.

Regulatory Status:
Approved by [Relevant Health Authority/Agency].

For wholesale inquiries, distribution, or B2B partnerships, please contact our sales team at [Contact Details].

Note: Always consult a healthcare provider before prescribing or using this medication.